000950 重药控股
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.5775.9829.30310.77810.460
总资产报酬率 ROA (%)0.4491.0851.7822.1832.604
投入资产回报率 ROIC (%)0.7741.7932.7953.4092.937

边际利润分析
销售毛利率 (%)7.4357.8748.5819.1789.364
营业利润率 (%)0.9181.2572.1162.4973.033
息税前利润/营业总收入 (%)2.2802.8843.7844.2674.591
净利润/营业总收入 (%)0.6820.9641.7152.0642.537

收益指标分析
经营活动净收益/利润总额(%)115.929107.83282.89486.85284.026
价值变动净收益/利润总额(%)45.50831.50220.07927.18322.222
营业外收支净额/利润总额(%)-0.1810.1432.5451.2250.224

偿债能力分析
流动比率 (X)1.2891.2731.1981.3031.292
速动比率 (X)1.0651.0881.0041.1121.084
资产负债率 (%)76.60175.58877.77676.32575.301
带息债务/全部投入资本 (%)68.49166.89369.01066.250--
股东权益/带息债务 (%)42.67446.16942.10647.09749.389
股东权益/负债合计 (%)22.41523.42123.94625.89027.653
利息保障倍数 (X)1.6721.7752.3462.4532.959

营运能力分析
应收账款周转天数 (天)154.791137.903144.535137.3560.000
存货周转天数 (天)43.89238.50040.38837.1000.000